Link Pharma Chem Ltd

NSE: BSE: 524748

₹24.86

(5.79%)

Wed, 25 Mar 2026, 10:37 pm

MTF 5xInvest in Link Pharma Chem Ltd with 5x Leverage Buy with MTF

Market Cap110.39M

PE Ratio81.48

Dividend0

Process Industries

Chemicals: Specialty

24.5K

Link Pharma Chem Price to Sales Ratio (P/S)

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	0	4.17	15.86	5.58	9.57	6.72	0	8.57	25.75	10.76	16.80	7.97	9.68	9.50	24.85	0	0
Price to book ratio	0.21	0.40	0.38	0.28	0.27	0.32	0.53	0.56	0.68	1.25	1.07	0.66	0.84	1.23	1.08	1.36	1.19
Price to sales ratio	0.15	0.33	0.27	0.16	0.17	0.15	0.25	0.41	0.36	0.52	0.45	0.30	0.30	0.33	0.42	0.63	0.59
Price to cash flow ratio	2.93	2.77	0	0.91	0	3.83	66.95	0	4	3.86	11.30	2.84	2.38	0	0	0	7.61
Enterprise value	65.19M	89.62M	117.37M	99.58M	115.14M	123.22M	139.89M	101.98M	103.82M	147.63M	134.99M	90.73M	93.09M	233.78M	248.16M	278.23M	207.31M
Enterprise value to EBITDA ratio	16.65	5.31	93.08	5.67	5.32	5.27	0	51.51	4.07	5.31	6.59	2.63	2.97	6.67	9.13	0	159.47
Debt to equity ratio	0.59	0.59	0.94	0.74	0.88	0.85	1.29	0.60	0.55	0.28	0.25	0.31	0.29	0.44	0.58	0.67	0.46
Return on equity %	0	10.23	2.47	5.16	2.88	4.97	-23.07	6.83	2.58	11.92	6.53	8.71	9.04	13.92	4.43	-9.48	-7.79

Link Pharma Chem Ltd Price to Sales Ratio

The Link Pharma Chem Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Link Pharma Chem Ltd's valuation, profitability, and overall financial performance. Tracking the Link Pharma Chem Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Link Pharma Chem Ltd (NSE: , BSE: 524748) is currently trading at ₹24.86, with a market capitalization of ₹110.39M. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Link Pharma Chem Ltd Price to Sales Ratio is essential for fundamental analysis.

Link Pharma Chem Ltd Price to Sales Ratio Current Value

The current Link Pharma Chem Ltd Price to Sales Ratio stands at 0.59.

The Link Pharma Chem Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Link Pharma Chem Ltd Price to Sales Ratio Historical Trend

The Link Pharma Chem Ltd Price to Sales Ratio has shown the following historical trend:

2024: 0.59
2023: 0.63
2022: 0.42
2021: 0.33
2020: 0.30

The decline in Link Pharma Chem Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.

What Link Pharma Chem Ltd Price to Sales Ratio Indicates for Investors

The Link Pharma Chem Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Link Pharma Chem Ltd Price to Sales Ratio Analysis Summary

The Link Pharma Chem Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Link Pharma Chem Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Link Pharma Chem Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800